Chembio Diagnostic Systems Inc.
Medford, NY
- UEI
- Z4B4JJDLQNK9
- CAGE
- 31YL0
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 3661 Horseblock Road a, Medford, NY 11763, USA
- Website
- chembio.com
- Founded
- 1986
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $310,777 |
| FY2025 | $120,440 |
| FY2024 | $42,101 |
| FY2023 | $48,110 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Agriculture | $310,777 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| Trustees Of Boston University | 75A50122C00028 | $1,008,228 |
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Tetracore, Inc. | Rockville, MD | 334519 Other Measuring and Controlling Device Manufacturing |
| Kickr Design LLC | — | 541330 Engineering Services |
| Vmrd Inc. | Pullman, WA | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Idexx Distribution, Inc. | Westbrook, ME | 423990 Other Miscellaneous Durable Goods Merchant Wholesalers |
| Euroimmun US Incorporated | Mountain Lakes, NJ | 423450 Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers |
About the company
Chembio Diagnostic Systems Inc., a Medford, New York-based manufacturer of rapid diagnostic test kits, operates as a federal prime contractor (99% of recent awards) selling specialized veterinary and human infectious-disease diagnostics across full-and-open procurement channels with no set-aside posture. The company manufactures immune-chromatographic point-of-care assays under primary NAICS codes 325413 (In-Vitro Diagnostic Substance Manufacturing) and 541712 (Research and Development in Biotechnology), with a twenty-year federal contracting history dating to 2005.
Chembio's federal footprint concentrates heavily on veterinary diagnostics for the USDA and public-health research for HHS. The top five funding agencies account for 62% of recent awards by count but 99% of combined potential value, a stark divergence reflecting Chembio's bimodal customer base: the USDA's Animal and Plant Health Inspection Service Veterinary Services dominates volume with 36 awards ($2.1 million combined potential value) for recurring purchase orders of DPP VetTB Assay Kits used in the Federal Bovine Tuberculosis Eradication program, while the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response anchors dollar value with four awards ($26.5 million combined potential value) for research and development of diagnostics addressing emerging public-health priorities. The CDC Pittsburgh accounts for four awards ($4.6 million), including a $3.2 million definitive contract awarded in September 2022 for FY 2021 BAA Topic 18.1 applied research on diagnostic technologies. Representative USDA work includes a February 2026 purchase order for $155,336.25 for Cervid DPP Test Kits, an August 2026 follow-on order for $155,550 for 600 DPP Vet Tuberculosis cervid diagnostic kits (600 units, delivery through March 2027), and a December 2024 purchase order for $96,347.50 for DPP VetTB Assay Kits. All USDA Veterinary Services awards are sole-source acquisitions under FAR 6.302-1, justified by Chembio's unique regulatory authorization as the sole licensed manufacturer of the DPP test approved for cervid tuberculosis screening. Chembio places eleven task orders under a USDA Blanket Purchase Agreement (AG6395B140053) valued at $738 thousand combined potential value.
Activity has remained episodic over recent years — three awards in 2021, declining to one in 2023, rebounding to four in 2024 and three in 2026 — with only one award (combined potential value $156 thousand) reaching ultimate completion within the next twenty-four months and thus facing recompete exposure. The company's one recent sub-award, a February 2026 engagement with Boston University as prime under the CARB-X Global Antibacterial Accelerator OTA, focuses on development of a rapid point-of-care IgA antibody detection assay for typhoid fever using Chembio's patented Dual Path Platform technology. Chembio's federal revenue base ($35 million obligated across all recent awards) and the concentration of small-dollar USDA orders suggest a lean operation anchored to manufacturing and supply rather than services; the company competes exclusively under full-and-open procurement and holds no parent-vehicle seats outside the single USDA BPA.
SBA capabilities narrative
At Chembio, our mission is to be a leader in the development, manufacture and commercialization of diagnostic solutions. We are dedicated to delivering exceptional products that provide ease of use, and rapid and accurate results at the point-of-care (POC). As a global company, we are committed to innovation and the highest quality standards.
Quick answers
Is Chembio Diagnostic Systems Inc. registered in SAM.gov?
Yes. Chembio Diagnostic Systems Inc.'s SAM.gov registration is active through January 2, 2027.
What is Chembio Diagnostic Systems Inc.'s CAGE code?
Chembio Diagnostic Systems Inc.'s CAGE code is 31YL0, and its Unique Entity ID (UEI) is Z4B4JJDLQNK9.
How much has Chembio Diagnostic Systems Inc. received in federal contracts?
Federal contracts obligated $120,440 to Chembio Diagnostic Systems Inc. in fiscal year 2025 and $521,427 in fiscal years 2023 through 2027.
How does Chembio Diagnostic Systems Inc. rank among federal contractors?
Chembio Diagnostic Systems Inc. ranked #87 in NAICS 325414 and #99 in NAICS 325413 in FY2025.
What is Chembio Diagnostic Systems Inc.'s most recent federal award?
Chembio Diagnostic Systems Inc.'s most recent federal contract award is The purpose of this purchase order is to enter into a firm fixed price contract for chembio diagnostic systems dual… (12639526P0213), from Marketing and Regulatory Programs Business Services (APHIS), on August 1, 2026.
On GovTribe
See Chembio Diagnostic Systems Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors